[Changes in various humoral immunity indicators during the treatment of rheumatoid arthritis with D-penicillamine (cuprenil)].
D000328:Adult; D000368:Aged; D000974:Antibodies, Antinuclear / Q000032:analysis; D000936:Antigen-Antibody Complex / Q000032:analysis; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000276:immunology*; D004247:DNA / Q000276:immunology; D006801:Humans; D007105:Immune Complex Diseases / Q000276:immunology*; D007136:Immunoglobulins / Q000032:analysis; D008875:Middle Aged; D010396:Penicillamine / Q000627:therapeutic use; D012217:Rheumatoid Factor / Q000032:analysis
D000974:Antibodies, Antinuclear; D000936:Antigen-Antibody Complex; D007136:Immunoglobulins; D004247:DNA; D012217:Rheumatoid Factor; D010396:Penicillamine
Zachowanie sie niektórych wskaźników odporności humoralnej w czasie leczenia D-penicylamina (cuprenilem) reumatoidalnego zapalenia stawów (R.Z.S.).